|
補助單位
|
計畫名稱
|
計畫編號
|
主持人
|
執行期間
|
|---|---|---|---|---|
|
科技部
|
孕婦的碘營養調查(第二年)
|
108-2314-B-075-010
|
黃君睿
|
108/08-109/07
|
|
產官學
晟德 |
A Phase II, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of CS02 Tablet in combination with metformin in patients with type 2 diabetes mellitus who have inadequate glycemic control on metformin alone
|
C17-126
|
陳涵栩
|
107/2~110/3
|
|
產官學
台灣禮來 |
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 versus Titrated Insulin Degludec on Glycemic Control in Patients with Type 2 Diabetes (SURPASS-3)
|
C19-055
|
林亮羽
|
108/4~110/11
|
|
Sanofi
|
A 30-week, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Alone or in Combination with Sulfonylurea.
|
C19-019
|
陳涵栩
|
108/06-110/06
|
|
Novo Nordisk
|
PIONEER 12 Multi-regional clinical trial: Efficacy and safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes mellitus treated with metformin.
|
C19-089
|
陳涵栩
|
108/08-110/09
|
|
|
|
|||
|
|
|
|
|
|
109年度榮總院內研究計畫
|
計畫名稱 |
計畫編號 |
主持人 |
執行期間 |
|---|---|---|---|
|
自體免疫甲狀腺疾病患者之基因體醫學、免疫學和碘營養之研究 |
V109B-035 |
黃君睿 |
109/01-109/12 |
|
糖尿病心衰竭患者生物標記及基因與預後相關性之研究(第三年) |
V109C-179 |
林亮羽 |
109/01-109/12 |
|
Diabetic Control and Diabetes Complications |
V109C-074 |
陳涵栩 |
108/01-109/12 |
最後更新：